secwatch.observer — SEC 8-K summary
======================================

Issuer:     Design Therapeutics, Inc. (DSGN)
CIK:        0001807120
Form:       8-K
Filed at:   2022-03-22T23:59:59+00:00
Accession:  0000950170-22-004311
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Design Therapeutics expands office/lab space by 4,900 sq ft via related-party lease amendment
--------------------------------------------------------------------------------

- Leases additional 4,900 sq ft in Carlsbad building; total leased space ~17,270 sq ft.
- Annual base rent for expansion initially ~$132,000, with 3% increases; rent abated through June 15, 2022.
- Expansion term runs to August 31, 2027, coterminous with existing lease.
- Landlord Crossing Holdings LLC controlled by Design's Executive Chair Pratik Shah (related-party transaction).
- Possession expected by July 1, 2022; delay penalty of one day rent abatement per day, up to 60 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1807120/000095017022004311/0000950170-22-004311-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1807120/000095017022004311/dsgn-20220318.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-004311

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer